VeriSign (VRSN)
(Delayed Data from NSDQ)
$175.48 USD
-7.20 (-3.94%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $175.42 -0.06 (-0.03%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
VRSN 175.48 -7.20(-3.94%)
Will VRSN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for VRSN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VRSN
VeriSign (VRSN) Q1 Earnings Up Y/Y, '24 Revenue View Tweaked
Watch These 6 Internet Stocks for Q1 Earnings: Beat or Miss?
VRSN: What are Zacks experts saying now?
Zacks Private Portfolio Services
How to Play VeriSign (VRSN) Ahead of Q1 Earnings Release
Is WisdomTree U.S. Multifactor ETF (USMF) a Strong ETF Right Now?
VeriSign (VRSN) Ascends While Market Falls: Some Facts to Note
Other News for VRSN
VeriSign (VRSN): Assessing the Potential for Value Investment
VeriSign price target lowered by $15 at Baird, here's why
Analysts Offer Insights on Technology Companies: Verisign (VRSN) and Intel (INTC)
VeriSign price target lowered by $21 at Citi, here's why
Weitz Multi Cap Equity Fund Q1 2024 Commentary